Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 May;40(5):1282–1284. doi: 10.1128/aac.40.5.1282

Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.

B E Korba 1, M R Boyd 1
PMCID: PMC163310  PMID: 8723485

Abstract

Penciclovir [9-(4-hydroxy-3-hydroxymethylbut-1-yI)guanine], an effective antiherpesvirus agent, was found to be a potent and selective antiviral agent against intracellular hepatitis B virus (HBV) replication (drug concentration at which a 10-fold decrease in HBV DNA from the average level in an untreated culture was observed [EC90], 1.6 microM) and extracellular virion release (EC90, 0.7 microM) by cultured human hepatoblastoma (2.2.15) cells. Acyclovir and three other related 9-alkoxypurines with activity against either herpesviruses or human immunodeficiency virus were uniformly inactive against HBV. The activity of penciclovir is discussed in relation to recent findings related to its mode of action against HBV.

Full Text

The Full Text of this article is available as a PDF (175.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander G. J., Fagan E. A., Hegarty J. E., Yeo J., Eddleston A. L., Williams R. Controlled clinical trial of acyclovir in chronic hepatitis B virus infection. J Med Virol. 1987 Jan;21(1):81–87. doi: 10.1002/jmv.1890210111. [DOI] [PubMed] [Google Scholar]
  2. Earnshaw D. L., Bacon T. H., Darlison S. J., Edmonds K., Perkins R. M., Vere Hodge R. A. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother. 1992 Dec;36(12):2747–2757. doi: 10.1128/aac.36.12.2747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Harnden M. R., Wyatt P. G., Boyd M. R., Sutton D. Synthesis and antiviral activity of 9-alkoxypurines. 1. 9-(3-Hydroxypropoxy)- and 9-[3-hydroxymethyl)propoxy]purines. J Med Chem. 1990 Jan;33(1):187–196. doi: 10.1021/jm00163a031. [DOI] [PubMed] [Google Scholar]
  4. Ilsley D. D., Lee S. H., Miller W. H., Kuchta R. D. Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action. Biochemistry. 1995 Feb 28;34(8):2504–2510. doi: 10.1021/bi00008a014. [DOI] [PubMed] [Google Scholar]
  5. Korba B. E., Gerin J. L. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antiviral Res. 1992 Jul 1;19(1):55–70. doi: 10.1016/0166-3542(92)90056-b. [DOI] [PubMed] [Google Scholar]
  6. Korba B. E., Milman G. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res. 1991 Mar-Apr;15(3):217–228. doi: 10.1016/0166-3542(91)90068-3. [DOI] [PubMed] [Google Scholar]
  7. Lee B., Luo W. X., Suzuki S., Robins M. J., Tyrrell D. L. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother. 1989 Mar;33(3):336–339. doi: 10.1128/aac.33.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pue M. A., Pratt S. K., Fairless A. J., Fowles S., Laroche J., Georgiou P., Prince W. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. J Antimicrob Chemother. 1994 Jan;33(1):119–127. doi: 10.1093/jac/33.1.119. [DOI] [PubMed] [Google Scholar]
  9. Saltzman R., Jurewicz R., Boon R. Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrob Agents Chemother. 1994 Oct;38(10):2454–2457. doi: 10.1128/aac.38.10.2454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schalm S. W., Heytink R. A., Van Buuren H. R., De Man R. A. Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis. J Hepatol. 1986;3 (Suppl 2):S137–S141. doi: 10.1016/s0168-8278(86)80112-x. [DOI] [PubMed] [Google Scholar]
  11. Schinazi R. F., Gosselin G., Faraj A., Korba B. E., Liotta D. C., Chu C. K., Mathé C., Imbach J. L., Sommadossi J. P. Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro. Antimicrob Agents Chemother. 1994 Sep;38(9):2172–2174. doi: 10.1128/aac.38.9.2172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sells M. A., Zelent A. Z., Shvartsman M., Acs G. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol. 1988 Aug;62(8):2836–2844. doi: 10.1128/jvi.62.8.2836-2844.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Shaw T., Amor P., Civitico G., Boyd M., Locarnini S. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother. 1994 Apr;38(4):719–723. doi: 10.1128/aac.38.4.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tsiquaye K. N., Slomka M. J., Maung M. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo. J Med Virol. 1994 Mar;42(3):306–310. doi: 10.1002/jmv.1890420319. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES